Sunday, 26 May 2019

Specials News

  • PathGEN chip can detect more than 70,000 microbes

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2013

    Dr Christopher Wong, founder and director, PathGEN Dx, Singapore, has dedicated his research to studying genomics since 2001 when he joined A*Star's Genomics Institute of Singapore (GIS) un...Read more

  • North China Pharma integrates R&D strength in its system

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally engaged in the production and distribution of pharmaceuticals and its ma...Read more

  • Asia faces an acute skills gap challenge

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a hurdle for Asia to emerge as a center of research and innovation. Co...Read more

  • Winners of BioSpectrum Asia Pacific BioScience Industry Award 2012

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2012

    Life Time Achievement Award: Dr John Ballard, Australia Person of the Year: Dr Il-Sup Huh, KoreaEntrepreneur of the Year: Dr Wilber Huang, Taiwan Product of the YearHypoMon, AIMEDICS Aust...Read more

  • Cognizant 'buys' AstraZeneca R&D Center in Bangalore?

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2014

    Cognizant Technology Solutions, India's $11 billion and No.2 software company, has reportedly purchased the iconic AstraZeneca Research Laboratory located in Hebbal, Bangalore, on the way t...Read more

  • BioSpectrum Asia releases Top 20 survey results

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2014

    ...Read more

  • International Clinical Trials Day Special

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 20 May, 2015

    May 20 is the recognized date for organizations, clinical research professionals, and the public to acknowledge the life changing achievements that result from the work performed by clinica...Read more

  • Challenge No 7: Money matters

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    Fluctuation in currency value has resulted in many companies showing a negative growth. Even inflation has a direct impact on the cost of living leading to attrition within an organization....Read more

  • Resmed dominates the niche sleep disorder market

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, ResMed continues to increase its effort to build awareness abou...Read more

  • Anuradha Rajput: Enjoy challenges to overcome them

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

    I received my MSc in Biochemistry in 1986, and my PhD in Biochemistry in 1992 both from the University of Mysore in India. I started my career working my way up through various hospital pos...Read more

  • Life expectancy gains worldwide: WHO

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 May, 2014

    Singapore: People everywhere are living longer, according to World Health Statistics 2014 and women are living longer than men with Japan, Spain and Singapore having longest life expectancy...Read more

  • Sinopharm demonstrates king size growth, yet again

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a large chunk of market share and widened its geographical coverage of...Read more

  • Asia's Fastest 50 bio-firms shine

    Specials |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    The annual list of Asia's fastest growing pharma companies, compiled painstakingly by the BioSpectrum Asia team, is out. A remarkable aspect of the growth of companies in 2012 is the gravit...Read more

  • MenAfriVac wins BioSpectrum product award for fight against meningitis

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Neisseria meningitidis (meningococcus) is a cause of the contagious bacterial meningitis that can lead to life-threatening infections in infants, children and young adults. Studies have ind...Read more

  • Q-Sera puts snake venom to blood collection use

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

    Q-Sera is a start-up firm that has put the lethal property of coagulation present in snake venom to good commercial use. The technology behind Q-Sera involves coating blood collection tubes...Read more

  • Dr. Reddy's makes a mark in the US generics market

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 percent. Dr. Reddy's generic version of fondaparinux, used for prophylax...Read more

  • eHealth Access redefines healthcare in India

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

    India-based start-up, eHealth Access (formely known as DialurDoctor) was established in the city of Hyderabad in 2010. Since its inception, the firm has revolutionized the healthcare space ...Read more

  • The breakthrough really is to explore new chemical classes for TB treatment'

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2012

    Novartis Institute for Tropical Diseases (NITD) is a public-private partnership between Novartis and the Singapore Economic Development Board and involves more than 100 international scient...Read more



Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls